CIK 0000873303 · Large accelerated filer
Sarepta Therapeutics, Inc.
Sign in to watch- Ticker
- SRPT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 930797222
- Phone
- 617-274-4000
- Business address
- 215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
- Former names
- Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-29 | Estepan Ian Michael Chief Financial Officer | Option exercise · Stock Option (right to buy) | −1,533 | 0 | ||
| 2024-12-27 | Estepan Ian Michael Chief Financial Officer | Gift | −250 | 33,696 | ||
| 2024-12-12 | Wigzell Hans Lennart Rudolf Director | Option exercise | +10,500 | $13.71 | $144K | 33,340 |
| 2024-12-12 | Wigzell Hans Lennart Rudolf Director | Sale | −10,500 | $124.84 | $1.3M | 22,840 |
| 2024-12-12 | Wigzell Hans Lennart Rudolf Director | Option exercise · Stock Options (right to buy) | −10,500 | 0 | ||
| 2024-12-05 | Boor Kathryn Jean Director | Sale | −1,636 | $125.55 | $205K | 5,880 |
| 2024-11-26 | Rothfuss Cristin EVP, General Counsel | Grant or award | +2,000 | 13,817 | ||
| 2024-11-26 | Rothfuss Cristin EVP, General Counsel | Grant or award · Stock Option (right to buy) | +4,000 | 4,000 | ||
| 2024-11-18 | Rodino-Klapac Louise Head of R&D, CSO | Shares withheld for taxes | −4,558 | $102.89 | $469K | 67,630 |
| 2024-09-12 | Connelly Deirdre P Director | Grant or award | +2,842 | 2,842 | ||
| 2024-09-12 | Connelly Deirdre P Director | Grant or award · Stock Option (right to buy) | +6,442 | 6,442 | ||
| 2024-09-04 | BEHRENS M KATHLEEN Director | Gift | −746 | 191,093 | ||
| 2024-08-30 | Estepan Ian Michael Chief Financial Officer | Sale | −5,985 | $137.36 | $822K | 33,946 |
| 2024-08-16 | Chambers Michael Andrew Director | Purchase | +13,106 | $133.07 | $1.7M | 260,102 |
| 2024-08-16 | Chambers Michael Andrew Director | Purchase | +18,284 | $134.06 | $2.5M | 278,386 |
| 2024-08-16 | Chambers Michael Andrew Director | Purchase | +5,648 | $134.66 | $761K | 284,034 |
| 2024-07-03 | BEHRENS M KATHLEEN Director | Option exercise | +15,000 | $13.90 | $209K | 191,839 |
| 2024-07-03 | BEHRENS M KATHLEEN Director | Option exercise · Stock Option (right to buy) | −15,000 | 0 | ||
| 2024-06-25 | Brown Ryan Edward EVP, General Counsel | Option exercise 10b5-1 | +23,500 | $62.77 | $1.5M | 56,086 |
| 2024-06-25 | Brown Ryan Edward EVP, General Counsel | Sale 10b5-1 | −7,644 | $158.07 | $1.2M | 48,442 |
Page 9 of 12 · 227 trades